The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of gastroesophageal reflux disease (GERD). NEXIUM was tested in adolescents ages 12 to 17 in a randomized, double-blind parallel group study in which a total of 149 patients, ages 12 to 17, with clinically diagnosed GERD were treated with either NEXIUM 20mg or NEXIUM 40 mg once a day for up to eight weeks. Reported side effects included headache,...
Read moreMany of you have like seeing pictures and videos, so I made sure to get both when I attended last month's Mental Health America Centennial... Read more »
Sometime in the mid-1990s my mother uncovered some photos of me as a child that I'd never seen before. I flipped through them and found one... Read more »
In a previous post I wrote about the theory that President Franklin Delano Roosevelt may have been hiding the fact that he had malignant... Read more »
First, I apologize for not writing last week from the Mental Health America conference as I had planned. The days were long; the emotions... Read more »
The winter after I was diagnosed with rheumatoid arthritis was one of the hardest for me. Living in New York City can be brutal no matter... Read more »